Bromelain (Stem Bromelain)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Bromelain (Stem Bromelain).

A proteolytic enzyme complex derived from Ananas comosus that exerts systemic anti-inflammatory and fibrinolytic effects by modulating the arachidonic acid cascade and cleaving cell surface signaling molecules.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

16131497

Molecular Weight

2025.2 g/mol

XLogP3 (Lipophilicity)

-4.6

IUPAC Name

(4S)-5-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-[[(2S,5S,8S,11S,14S,17S,20S,34S)-11-(2-carboxyethyl)-17-(carboxymethyl)-34-(3-carboxypropanoylamino)-2-[(1R)-1-hydroxyethyl]-5,14-bis(1H-indol-3-ylmethyl)-8-(2-methylsulfanylethyl)-3,6,9,12,15,18,23,31,35-nonaoxo-1,4,7,10,13,16,19,24,30-nonazacyclopentatriacontane-20-carbonyl]amino]-5-oxopentanoic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Quercetin for dual inhibition of inflammatory mediators and enhanced capillary permeability regulation
Trypsin for synergistic proteolytic debridement and reduction of localized edema

Biological Formulation Enhancers

Enteric coating for protection against gastric acid denaturation to ensure systemic bioavailability
Calcium for stabilization of the enzyme's tertiary structure against thermal degradation

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Bromelain (Stem Bromelain) across standard consumer modalities.

💊 Standard Capsules

Standard gelatin capsules risk premature release in the stomach, necessitating acid-resistant polymers to prevent proteolytic inactivation by gastric pepsin.

🍬 Gummy & Pectin Formats

The high water activity and thermal requirements of gummy manufacturing promote enzymatic autolysis, leading to a significant loss of biological potency.

🔬 Thin-Film Oral Strips

The high dosage required for clinical efficacy exceeds the typical 50mg payload capacity of thin-film matrices, complicating the delivery of therapeutic GDU levels.

For Brand Founders

Formulate with Bromelain (Stem Bromelain)

Ready to launch a product featuring Bromelain (Stem Bromelain)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Bromelain (Stem Bromelain) Bioavailability

Need absolute proof that your Bromelain (Stem Bromelain) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Bromelain (Stem Bromelain) Degradation Testing

Is your Bromelain (Stem Bromelain) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation